Cargando…
Preoperative Serum IL-12p40 Is a Potential Predictor of Kasai Portoenterostomy Outcome in Infants with Biliary Atresia
The standard-of-care treatment for biliary atresia (BA) is surgical restoration of bile flow by Kasai portoenterostomy. We aimed to study serum interleukin- (IL-) 12p40, a natural antagonist for the proinflammatory IL-12p70, and its relation to surgical outcomes of BA. The study included 75 infants...
Autores principales: | Goda, Shaimaa Samy, Khedr, Mohamed Ahmed, Elshenawy, Soha Zaki, Ibrahim, Tarek Mohamed, El-Araby, Hanaa Ahmed, Sira, Mostafa Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447261/ https://www.ncbi.nlm.nih.gov/pubmed/28588613 http://dx.doi.org/10.1155/2017/9089068 |
Ejemplares similares
-
The extended Kasai portoenterostomy for biliary atresia: A preliminary report
por: Ramachandran, Priya, et al.
Publicado: (2016) -
Steroids after the Kasai procedure for biliary atresia: the effect of age at Kasai portoenterostomy
por: Tyraskis, Athanasios, et al.
Publicado: (2015) -
α-Smooth muscle actin expression predicts the outcome of Kasai portoenterostomy in biliary atresia
por: Ramachandran, Priya, et al.
Publicado: (2019) -
Long-Term Effects of Kasai Portoenterostomy for Biliary Atresia Treatment in Russia
por: Degtyareva, Anna, et al.
Publicado: (2020) -
Serum FGF19 predicts outcomes of Kasai portoenterostomy in biliary atresia
por: Nyholm, Iiris, et al.
Publicado: (2023)